Also how would we control for environmental health effects, or even interactions between multiple product variances. This kind of testing would be wildly expensive, pose potential public health risks, and the data collected would be coarse and noisy at best
The only difference is it very slightly adjusts the quantity - and does so in a way that is within existing allowed tolerances, so effectively this might already be happening, just we aren't collecting the results.
https://en.wikipedia.org/wiki/Estimated_sign
By tightening the required tolerances, londons_explore's proposal could be implemented without exposing anybody to different levels of product than are already permitted.
However, you have to get people to tell you how much product they use, which brands, how often, and not lie about it. That's basically impossible without antisocial levels of monitoring (which supermarkets probably already do, but which they don't want to tell their customers they do).
It's like the early days of mass customer data tracking where they'd tell customers they were probably pregnant, or probably gay, or whatever. People didn't receive the information in a way that suggested they were happy about the data being gathered.
It's probably too unethical to even use that data. Unless you're only trying to sell more crap, then it's A-OK! /s
Here's how it would work:
* Companies that make products would randomly increase by 5% or decrease by 5% the dosage of each ingredient in a product headed to a specific town.
* The government would publish A/B groupings for every town in the US and every chemical they track.
* Average health data would be collected, and whenever a specific chemicals A/B group difference exceeds some threshold, investigation is done.
The main downside is production costs of products goes up, since every product will now have a final step of adding all the A/B adjustment doses to the bottle before sealing. But I believe this is worth it for rooting out chemicals that have low level yet very widespread negative effects.